CURANEX PHARMACEUTICALS INC
CURX · NASDAQ
Updated at 2026-10-13 13:17:03
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $5.04
- Previous Close
- $4.88
- Volume
- 7.89K
- Market Cap
- $7.65M
- P/E Ratio
- --
- EPS
- $-6.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2 JERICHO PLAZA, JERICHO, NY, UNITED STATES, 11753
- Country
- US
- Listing Date
- 2025-08-26
- Fiscal Year End
- December
- Shares Outstanding
- 28.36M
- CIK
- 0001434893
- Website
- www.curanexpharma.com
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. The company is headquartered in Jericho, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.32M
2026-03-31
$3.14M
2025-12-31
$3.05M
2025-09-30
$951.32K
Net Income
2026-06-30
-$3.29M
2026-03-31
-$3.15M
2025-12-31
-$3.07M
2025-09-30
-$954.05K
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.03
2026-03-31
$-2.22
2025-12-31
$-2.16
2025-09-30
$-0.04
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.25M
2026-03-31
-$3.14M
2025-12-31
-$3.05M
2025-09-30
-$934.53K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.32M | $3.14M | $3.05M | $951.32K |
| Net Income | -$3.29M | -$3.15M | -$3.07M | -$954.05K |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.03 | $-2.22 | $-2.16 | $-0.04 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.25M | -$3.14M | -$3.05M | -$934.53K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.